Simon's most recent trade in JFrog Ltd was a trade of 32,779 Ordinary Shares done at an average price of $41.7 . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 41.67 per share. | 08 Jul 2025 | 32,779 | 4,242,124 | - | 41.7 | 1,365,901 | Ordinary Shares |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 42.27 per share. | 08 Jul 2025 | 2,221 | 4,239,903 | - | 42.3 | 93,882 | Ordinary Shares |
| Luminar Technologies Inc -... | Matthew J. Simoncini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 61,576 | 78,097 | - | 0 | Class A Common Stock | |
| Iron Mountain - REIT | Doyle R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 347 | 44,369 | - | - | Phantom Stock | |
| Iron Mountain - REIT | Doyle R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 340 | 44,021 | - | - | Phantom Stock | |
| SSR Mining Inc | Simon A. Fish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 4,535 | 138,171 | - | - | Deferred Share Unit | |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 4,360 | 4,360 | - | - | Performance Stock Units | |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 4,359 | 4,359 | - | - | Restricted Stock Units | |
| SSR Mining Inc | Simon A. Fish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 1,894 | 135,530 | - | - | Deferred Share Unit | |
| Apollo Global | David Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 1,446 | 13,263 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 01 Jul 2025 | 876 | 64,864 (0%) | 0% | 20.1 | 17,625 | Common Stock |
| Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.94 per share. | 01 Jul 2025 | 374 | 65,740 (0%) | 0% | 16.9 | 6,336 | Common Stock |
| Union Pacific | Doyle R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 351 | 2,300 | - | - | Phantom Stock | |
| BioCardia Inc. | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 30 Jun 2025 | 72,289 | 192,654 (2%) | 1% | 2.1 | 150,000 | Common Stock |
| BioCardia Inc. | Simon H. Stertzer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jun 2025 | 72,289 | 177,275 | - | - | Warrant (right to buy) | |
| Fiserv | Doyle R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 285 | 44,601 | - | - | Deferred Compensation Notional Units | |
| EverCommerce Inc | Richard A. Simonson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 20,942 | 77,465 | - | 0 | Common Stock | |
| Aeva Technologies Inc | Hrach Simonian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 5,968 | 111,291 | - | 0 | Common Stock | |
| Autodesk | Anna Christine Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 846 | 1,026 (0%) | 0% | 0 | Common Stock | |
| Aeva Technologies Inc | Hrach Simonian | Director | Sale of securities on an exchange or to another person at price $ 24.82 per share. | 16 Jun 2025 | 60,868 | 3,622,249 | - | 24.8 | 1,510,847 | Common Stock |
| Aeva Technologies Inc | Hrach Simonian | Director | Sale of securities on an exchange or to another person at price $ 25.49 per share. | 16 Jun 2025 | 25,210 | 3,597,039 | - | 25.5 | 642,696 | Common Stock |
| Aeva Technologies Inc | Hrach Simonian | Director | Sale of securities on an exchange or to another person at price $ 23.91 per share. | 16 Jun 2025 | 13,922 | 3,683,117 | - | 23.9 | 332,932 | Common Stock |
| Couchbase Inc | Richard A. Simonson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2025 | 1,013 | 50,771 | - | 0 | Common Stock | |
| Stagwell Inc - Ordinary Sh... | Irwin D. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 30,000 | 205,921 | - | 0 | Class A Common Stock | |
| Roku Inc - Ordinary Shares... | Laurie Simon Hodrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,140 | 3,140 | - | - | Stock Options (right to buy) | |
| Roku Inc - Ordinary Shares... | Laurie Simon Hodrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 1,847 | 1,847 | - | - | Restricted Stock Unit | |
| Evercore Inc - Ordinary Sh... | Simon Manwaring Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 527 | 9,351 (0%) | 0% | 0 | Shares of Class A common stock, par value $0.01 per share | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 42.39 per share. | 10 Jun 2025 | 28,100 | 4,281,803 | - | 42.4 | 1,191,159 | Ordinary Shares |
| Avidity Biosciences Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 10,034 | 10,034 | - | - | Stock Option (Right to Buy) | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 43.28 per share. | 10 Jun 2025 | 6,900 | 4,274,903 | - | 43.3 | 298,632 | Ordinary Shares |
| Avidity Biosciences Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 6,692 | 6,692 | - | 0 | Common Stock | |
| Aemetis Inc | Timothy Alan Simon | Director | Sale or transfer of securities back to the company at price $ 1.98 per share. | 09 Jun 2025 | 10,371 | 50,261 (0%) | 0% | 2.0 | 20,582 | Common Stock |
| Aemetis Inc | Timothy Alan Simon | Director | Sale or transfer of securities back to the company at price $ 1.98 per share. | 09 Jun 2025 | 5,000 | 45,261 (0%) | 0% | 2.0 | 9,923 | Common Stock |
| Aemetis Inc | Timothy Alan Simon | Director | Sale or transfer of securities back to the company at price $ 1.98 per share. | 09 Jun 2025 | 4,629 | 40,632 (0%) | 0% | 2.0 | 9,187 | Common Stock |
| Roku Inc - Ordinary Shares... | Laurie Simon Hodrick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 2,029 | 6,108 (0%) | 0% | 0 | Class A Common Stock | |
| Roku Inc - Ordinary Shares... | Laurie Simon Hodrick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 2,029 | 0 | - | - | Restricted Stock Unit | |
| Immunic Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 150,000 | 150,000 | - | - | Stock Option | |
| Microvision Inc. | Simon Biddiscombe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 87,642 | 87,642 | - | - | Restricted Stock Units | |
| Microvision Inc. | Simon Biddiscombe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 20,112 | 225,278 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc. | Simon Biddiscombe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 20,112 | 0 | - | - | Restricted Stock Units | |
| MoonLake Immunotherapeutic... | Simon John Sturge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,682 | 6,682 | - | - | Option to Buy | |
| Alarm.com Holdings Inc | Simone Wu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 2,510 | 12,633 (0%) | 0% | 0 | Common Stock | |
| Farmers & Merchants Bancor... | Simon R. Frank | Director | Grant, award, or other acquisition of securities at price $ 22.96 per share. | 05 Jun 2025 | 762 | 2,620 (0%) | 0% | 23.0 | 17,496 | Common Stock |
| HubSpot Inc | Jay Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 400 | 7,242 (0%) | 0% | 0 | Common Stock | |
| Tilray Brands Inc | Irwin D. Simon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 02 Jun 2025 | 1,178,109 | 4,424,593 | - | 0.4 | 483,025 | Common Stock (RSUs) |
| Tilray Brands Inc | Irwin D. Simon | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Jun 2025 | 1,178,109 | 0 | - | - | Restricted Stock Units ("LTIP RSUs") | |
| Tilray Brands Inc | Irwin D. Simon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 02 Jun 2025 | 647,960 | 3,776,633 | - | 0.4 | 265,664 | Common Stock (RSUs) |
| Trevi Therapeutics Inc | Farrell Simon | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2025 | 72,000 | 110,400 | - | - | Performance Stock Option (right to buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 66,666 | 401,778 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.38 per share. | 30 May 2025 | 26,234 | 375,544 (0%) | 0% | 69.4 | 1,820,115 | Common Stock |
| Couchbase Inc | Richard A. Simonson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,711 | 49,758 | - | 0 | Common Stock | |
| Iron Mountain - REIT | Doyle R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 2,249 | 43,680 | - | - | Phantom Stock | |
| SmartKem Inc | Simon Ogier | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 77,656 | 77,656 | - | - | Stock Option (right to Buy) | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2025 | 974 | 17,237 (0%) | 0% | - | Common Stock | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2025 | 974 | 1,949 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.78 per share. | 25 May 2025 | 457 | 16,780 (0%) | 0% | 47.8 | 21,835 | Common Stock |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2025 | 321 | 16,413 (0%) | 0% | - | Common Stock | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2025 | 321 | 2,894 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.78 per share. | 25 May 2025 | 150 | 16,263 (0%) | 0% | 47.8 | 7,167 | Common Stock |
| Sotera Health Co | Christopher A. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,132 | 19,132 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 1,525 | 4,577 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 1,525 | 16,311 (0%) | 0% | - | Common Stock | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 937 | 10,313 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 937 | 16,532 (0%) | 0% | - | Common Stock | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.18 per share. | 22 May 2025 | 716 | 15,595 (0%) | 0% | 44.2 | 31,633 | Common Stock |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 527 | 3,692 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 527 | 15,033 (0%) | 0% | - | Common Stock | |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.18 per share. | 22 May 2025 | 440 | 16,092 (0%) | 0% | 44.2 | 19,439 | Common Stock |
| Trupanion Inc | Simon Wheeler | EVP, Trupanion International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.18 per share. | 22 May 2025 | 247 | 14,786 (0%) | 0% | 44.2 | 10,912 | Common Stock |
| JFrog Ltd | Frederic Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 5,471 | 4,309,903 | - | 0 | Ordinary Shares | |
| Steven Madden Ltd. | Arian Simone Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 4,860 | 15,017 (0%) | 0% | 0 | Common Stock par value $0.0001 per share | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 12,191 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 46,342 | 46,342 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 21,405 | 335,112 (0%) | 0% | - | Common Stock | |
| Mercury General Corp. | Ximeng Simon Zhang | See Remarks | Purchase of securities on an exchange or from another person at price $ 61.91 per share. | 16 May 2025 | 1,500 | 1,500 (0%) | 0% | 61.9 | 92,866 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.31 per share. | 15 May 2025 | 7,089 | 313,707 (0%) | 0% | 70.3 | 498,428 | Common Stock |
| TriNet Group Inc | Michael Q. Simonds | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.88 per share. | 15 May 2025 | 3,899 | 120,312 (0%) | 0% | 83.9 | 327,048 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.38 per share. | 15 May 2025 | 2,391 | 320,796 (0%) | 0% | 69.4 | 165,888 | Common Stock |
| TriNet Group Inc | Michael Q. Simonds | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.88 per share. | 15 May 2025 | 1,707 | 118,605 (0%) | 0% | 83.9 | 143,183 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.80 per share. | 15 May 2025 | 1,338 | 148,462 (0%) | 0% | 60.8 | 81,350 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,338 | 0 | - | - | Restricted Stock Units | |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.80 per share. | 15 May 2025 | 1,222 | 149,828 (0%) | 0% | 60.8 | 74,298 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,222 | 3,510 | - | - | Performance Stock Units | |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.80 per share. | 15 May 2025 | 1,150 | 147,439 (0%) | 0% | 60.8 | 69,920 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,150 | 0 | - | - | Performance Stock Units | |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.80 per share. | 15 May 2025 | 702 | 148,798 (0%) | 0% | 60.8 | 42,682 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 702 | 3,510 | - | - | Restricted Stock Units | |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.80 per share. | 15 May 2025 | 366 | 148,096 (0%) | 0% | 60.8 | 22,253 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.80 per share. | 15 May 2025 | 335 | 149,493 (0%) | 0% | 60.8 | 20,368 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.80 per share. | 15 May 2025 | 315 | 147,124 (0%) | 0% | 60.8 | 19,152 | Common Stock |
| TriNet Group Inc | Michael Q. Simonds | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 72.68 per share. | 15 May 2025 | 284 | 118,889 (0%) | 0% | 72.7 | 20,641 | Common Stock |
| Microchip Tech | Richard J. Simoncic | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.80 per share. | 15 May 2025 | 192 | 148,606 (0%) | 0% | 60.8 | 11,674 | Common Stock |
| Fiserv | Doyle R. Simons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 6,594 | 0 | - | - | Stock Option (right to buy) | |
| Fiserv | Doyle R. Simons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.56 per share. | 14 May 2025 | 6,594 | 84,382 (0%) | 0% | 40.6 | 267,453 | Common Stock |
| Somnigroup International Inc. | Simon John Dyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 2,337 | 2,337 | - | - | Restricted Stock Units | |
| Fiserv | Doyle R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 1,608 | 77,788 (0%) | 0% | 0 | Common Stock | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 42.29 per share. | 13 May 2025 | 16,539 | 4,304,432 | - | 42.3 | 699,434 | Ordinary Shares |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 41.70 per share. | 13 May 2025 | 13,761 | 4,320,971 | - | 41.7 | 573,834 | Ordinary Shares |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 40.79 per share. | 13 May 2025 | 4,700 | 4,334,732 | - | 40.8 | 191,713 | Ordinary Shares |
| AEye Inc - Ordinary Shares... | Doron Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 17,959 | 40,251 | - | 0 | Common Stock |